Résumé
Le traitement par oxygénothérapie hyperbare (OHB) lors des intoxications au monoxyde de carbone est utilisé depuis plus de 50 ans. Néanmoins, le protocole à appliquer et le sous-groupe de patients pouvant bénéficier de l’OHB restent débattus. La physiopathologie de l’intoxication au monoxyde de carbone est complexe, expliquant la diversité des tableaux cliniques retrouvés neurologiques (troubles de la conscience et syndrome postintervallaire) mais aussi cardiaques (ischémie à coronaires saines notamment). La physiopathologie fait intervenir une hypoxie anémique par formation de carboxyhémoglobine mais aussi une hypoxie hypoxique par blocage de la chaîne respiratoire au niveau de la cytochrome oxydase, un stress oxydatif et des lésions d’ischémie-reperfusion. La carboxyhémoglobine (veineuse ou artérielle) n’est pas à prendre en compte pour le traitement; le dosage de la troponine Ic au moindre doute est souhaitable. Les bases de traitement par l’OHB reposent d’abord sur des arguments physiopathologiques: détoxification plus rapide des protéines héminiques, effet antioxydant et amélioration de la physiologie cérébrale (diminution de la pression intracrânienne, diminution de l’oedème et préservation de la zone de pénombre). Les autres arguments sont issus des essais thérapeutiques randomisés. Quatre des cinq études randomisées utilisant une OHB avec une pression supérieure à 2 ATA étaient positives. Deux études à 2 ATA étaient négatives. Ainsi, les recommandations européennes et américaines suggèrent l’utilisation d’OHB à 2,5 ATA au moins dans les situations à risque de séquelles neurologiques (tout signe neurologique objectif y compris perte de connaissance), en cas d’atteinte cardiaque ou de grossesse. Il faut insister sur un traitement par oxygénothérapie à fort débit pendant 8-12 heures en cas de non-indication de l’OHB.
Abstract
Hyperbaric oxygen (HBO) is used since more than 50 years for carbon monoxide poisoning. However, HBO protocols and indications are still debated. Neurological (coma and delayed neuropsychological sequelae) and cardiac (ischemic changes with normal coronary arteries) clinical scenarios are explained by complex mechanisms. Carboxyhemoglobin formation, cytochrome oxydase inhibition, oxidative stress, as well as ischemia-reperfusion phenomenon are among these mechanisms. Venous and arterial carboxyhemoglobin levels are not correlated with the patient’s final prognosis and thus not mandatory for indicating the treatment. Conversely, troponin IC measurement is strongly recommended if myocardial involvement is suspected. HBO treatment relies on mechanistic bases: earlier detoxification, anti-oxidant properties, and improvement in cerebral physiology (decrease in intracranial pressure and oedema, and ischemic penumbra preservation). Clinical basis is assessed by the results of the randomized clinical trials (RCTs). Four among the 5 RCTs using > 2 ATA OHB protocols were positive. Two RCTs at 2 ATA level were negative. Therefore, international guidelines recommend OHB with at least 2.5 ATA in patients at risk of delayed neuropsychological sequelae, whatever the objective neurological signs are, in pregnant women, and patients with myocardial involvement. If OHB is not required, normobaric oxygen with high flow rates during at least 8-12 hours is mandatory.
Références
Thom SR, Bhopale VM, Milovanova TM, et al (2010) Plasma biomarkers in carbon monoxide poisoning. Clin Toxicol (Phila) 48(1):47–56
Weaver LK, Hopkins RO, Chan KJ, et al (2002) Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 347(14):1057–1067
Luomanmaki K, Coburn RF (1969) Effects of metabolism and distribution of carbon monoxide on blood and body stores. Am J Physiol 217(2):354–363
Miro O, Casademont J, Barrientos A, et al (1998) Mitochondrial cytochrome c oxidase inhibition during acute carbon monoxide poisoning. Pharmacol Toxicol 82(4):199–202
Thom SR (1990) Carbon monoxide-mediated brain lipid peroxidation in the rat. J Appl Physiol 68(3):997–1003
Thom SR (1992) Dehydrogenase conversion to oxidase and lipid peroxidation in brain after carbon monoxide poisoning. J Appl Physiol 73(4):1584–1589
Brown SD, Piantadosi CA (1992) Recovery of energy metabolism in rat brain after carbon monoxide hypoxia. J Clin Invest 89(2):666–672
Thom SR (1993) Leukocytes in carbon monoxide-mediated brain oxidative injury. Toxicol Appl Pharmacol 123(2):234–247
Thom SR, Fisher D, Xu YA, et al (1999) Role of nitric oxide-derived oxidants in vascular injury from carbon monoxide in the rat. Am J Physiol 276(3 Pt 2):H984–H992
Thom SR (1993) Leukocytes in carbon monoxide-mediated brain oxidative injury. Toxicol Appl Pharmacol 123(2):234–247
Thom SR, Ohnishi ST, Ischiropoulos H (1994) Nitric oxide released by platelets inhibits neutrophil B2 integrin function following acute carbon monoxide poisoning. Toxicol Appl Pharmacol 128(1):105–110
Kavakli HS, Erel O, Delice O, et al (2011) Oxidative stress increases in carbon monoxide poisoning patients. Hum Exp Toxicol 30(2):160–164
Garrabou G, Inoriza JM, Moren C, et al (2011) Mitochondrial injury in human acute carbon monoxide poisoning: the effect of oxygen treatment. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 29(1):32–51
Cronje FJ, Carraway MS, Freiberger JJ, et al (2004) Carbon monoxide actuates O(2)-limited heme degradation in the rat brain. Free Radic Biol Med 37(11):1802–1812
Favory R, Lancel S, Tissier S, et al (2006) Myocardial dysfunction and potential cardiac hypoxia in rats induced by carbon monoxide inhalation. Am J Respir Crit Care Med 174(3):320–325
Iheagwara KN, Thom SR, Deutschman CS, Levy RJ (2007) Myocardial cytochrome oxidase activity is decreased following carbon monoxide exposure. Biochim Biophys Acta 1772(9):1112–1116
Fracasso T, Pfeiffer H, Michaud K, et al (2011) Immunohistochemical expression of fibronectin and C5b-9 in the myocardium in cases of carbon monoxide poisoning. Int J Legal Med 125(3):377–384
Satran D, Henry CR, Adkinson C, et al (2005) Cardiovascular manifestations of moderate to severe carbon monoxide poisoning. J Am Coll Cardiol 45(9):1513–1516
Henry CR, Satran D, Lindgren B, et al (2006) Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning. JAMA 295(4):398–402
Kalay N, Ozdogru I, Cetinkaya Y, et al (2007) Cardiovascular effects of carbon monoxide poisoning. Am J Cardiol 99(3):322–324
Teksam O, Gumus P, Bayrakci B, et al (2010) Acute cardiac effects of carbon monoxide poisoning in children. Eur J Emerg Med 17(4):192–196
Piantadosi CA, Zhang J, Levin ED, et al (1997) Apoptosis and delayed neuronal damage after carbon monoxide poisoning in the rat. Exp Neurol 147(1):103–114
Thom SR, Bhopale VM, Fisher D, et al (2004) Delayed neuropathology after carbon monoxide poisoning is immune-mediated. Proc Natl Acad Sci USA 101(37):13660–13665
Hampson NB, Hauff NM (2008) Carboxyhemoglobin levels in carbon monoxide poisoning: do they correlate with the clinical picture? Am J Emerg Med 26(6):665–669
Weaver LK, Valentine KJ, Hopkins RO (2007) Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen. Am J Respir Crit Care Med 176(5):491–497
Brvar M, Finderle Z, Suput D, Bunc M (2006) S100B protein in conscious carbon monoxide-poisoned rats treated with normobaric or hyperbaric oxygen. Crit Care Med 34(8):2228–2230
Rasmussen LS, Poulsen MG, Christiansen M, Jansen EC (2004) Biochemical markers for brain damage after carbon monoxide poisoning. Acta Anaesthesiol Scand 48(4):469–473
Cakir Z, Aslan S, Umudum Z, et al (2010) S-100beta and neuron-specific enolase levels in carbon monoxide-related brain injury. Am J Emerg Med 28(1):61–67
Yardan T, Cevik Y, Donderici O, et al (2009) Elevated serum S-100beta protein and neuron-specific enolase levels in carbon monoxide poisoning. Am J Emerg Med 27(7):838–842
Ide T, Kamijo Y (2009) The early elevation of interleukin 6 concentration in cerebrospinal fluid and delayed encephalopathy of carbon monoxide poisoning. Am J Emerg Med 27(8):992–996
Ide T, Kamijo Y (2008) Myelin basic protein in cerebrospinal fluid: a predictive marker of delayed encephalopathy from carbon monoxide poisoning. Am J Emerg Med 26(8):908–912
Pace N, Strajman E, Walker EL (1950) Acceleration of carbon monoxide elimination in man by high pressure oxygen. Science 111(2894):652–654
Rogatsky GG, Kamenir Y, Mayevsky A (2005) Effect of hyperbaric oxygenation on intracranial pressure elevation rate in rats during the early phase of severe traumatic brain injury. Brain Res 1047(2):131–136
Rockswold GL, Ford SE, Anderson DC, et al (1992) Results of a prospective randomized trial for treatment of severely brain-injured patients with hyperbaric oxygen. J Neurosurg 76(6):929–934
Thom SR, Fisher D, Zhang J, et al (2004) Neuronal nitric oxide synthase and N-methyl-D-aspartate neurons in experimental carbon monoxide poisoning. Toxicol Appl Pharmacol 194(3):280–295
Wang P, Zeng T, Zhang CL, et al (2009) Lipid peroxidation was involved in the memory impairment of carbon monoxide-induced delayed neuron damage. Neurochem Res 34(7):1293–1298
Thom SR, Bhopale VM, Fisher D (2006) Hyperbaric oxygen reduces delayed immune-mediated neuropathology in experimental carbon monoxide toxicity. Toxicol Appl Pharmacol 213(2):152–159
Atochin DN, Fisher D, Demchenko IT, Thom SR (2000) Neutrophil sequestration and the effect of hyperbaric oxygen in a rat model of temporary middle cerebral artery occlusion. Undersea Hyperb Med 27(4):185–190
Yang ZJ, Camporesi C, Yang X, et al (2002) Hyperbaric oxygenation mitigates focal cerebral injury and reduces striatal dopamine release in a rat model of transient middle cerebral artery occlusion. Eur J Appl Physiol 87(2):101–107
Mrsic-Pelcic J, Pelcic G, Vitezic D, et al (2004) Hyperbaric oxygen treatment: the influence on the hippocampal superoxide dismutase and Na+,K+-ATPase activities in global cerebral ischemiaexposed rats. Neurochem Int 44(8):585–594
Raphael JC, Elkharrat D, Jars-Guincestre MC, et al (1989) Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 2(8660):414–419
Brown SD, Piantadosi CA (1992) Recovery of energy metabolism in rat brain after carbon monoxide hypoxia. J Clin Invest 89(2):666–672
Thom SR, Mendiguren I, Hardy K, et al (1997) Inhibition of human neutrophil beta2-integrin-dependent adherence by hyperbaric O2. Am J Physiol 272(3 Pt 1):C770–C777
Thom SR, Taber RL, Mendiguren II, et al (1995) Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Ann Emerg Med 25(4):474–480
Ducasse JL, Celsis P, Marc-Vergnes JP (1995) Non-comatose patients with acute carbon monoxide poisoning: hyperbaric or normobaric oxygenation? Undersea Hyperb Med 22(1):9–15
Scheinkestel CD, Bailey M, Myles PS, et al (1999) Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomized controlled clinical trial. Med J Aust 170:203–210
Juurlink DN, Buckley NA, Stanbrook MB, et al (2005) Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev (1):CD002041
Buckley NA, Juurlink DN, Isbister G, et al (2011) Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev (4):CD002041
Hampson NB, Dunford RG, Ross DE, et al (2006) A prospective, randomized clinical trial comparing two hyperbaric treatment protocols for carbon monoxide poisoning. Undersea Hyperb Med 33(1):27–32
Hopkins RO, Weaver LK, Valentine KJ, et al (2007) Apolipoprotein E genotype and response of carbon monoxide poisoning to hyperbaric oxygen treatment. Am J Respir Crit Care Med 176(10):1001–1006
Annane D, Chevret S, Raphael JC (2011) Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials: reply to comment by Birmingham and Hoffman. Intensive Care Med
Hawkins M, Harrison J, Charters P (2000) Severe carbon monoxide poisoning: outcome after hyperbaric oxygen therapy. Br J Anaesth 84(5):584–586
Ginsberg MD, Myers RE (1974) Fetal brain damage following maternal carbon monoxide intoxication: an experimental study. Acta Obstet Gynecol Scand 53(4):309–317
Caravati EM, Adams CJ, Joyce SM, Schafer NC (1988) Fetal toxicity associated with maternal carbon monoxide poisoning. Ann Emerg Med 17(7):714–717
Cramer CR (1982) Fetal death due to accidental maternal carbon monoxide poisoning. J Toxicol Clin Toxicol 19(3):297–301
Longo LD (1977) The biological effects of carbon monoxide on the pregnant woman, fetus, and newborn infant. Am J Obstet Gynecol 129(1):69–103
Hu H, Pan X, Wan Y, et al (2011) Factors affecting the prognosis of patients with delayed encephalopathy after acute carbon monoxide poisoning. Am J Emerg Med 29(3):261–264
Chang DC, Lee JT, Lo CP, et al (2010) Hyperbaric oxygen ameliorates delayed neuropsychiatric syndrome of carbon monoxide poisoning. Undersea Hyperb Med 37(1):23–33
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Favory, R., Poissy, J., Parmentier, E. et al. Intoxication au monoxyde de carbone et place de l’oxygénothérapie hyperbare. Réanimation 20, 493–501 (2011). https://doi.org/10.1007/s13546-011-0327-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13546-011-0327-y